Tectonic Therapeutic (TECX) Gains from Investment Securities (2017 - 2026)
Tectonic Therapeutic (TECX) reported Gains from Investment Securities of $2.2 million for Q1 2026, up 6724.72% year-over-year from $31891.0 in Q1 2025, and up 186.38% quarter-over-quarter from $760000.0 in Q4 2025.
Tectonic Therapeutic (TECX) Gains from Investment Securities (2017 - 2026) Analysis & Trends
Tectonic Therapeutic (TECX) has 10 years of Gains from Investment Securities data on file, last reported at $2.2 million in Q1 2026.
- Gains from Investment Securities for Q1 2026 came in at $2.2 million, up 6724.72% year-over-year; the trailing twelve-month figure through Mar 2026 was $2.2 million (up 6724.72% YoY), and the FY2025 annual result was $2.0 million, up 2010.1% from the prior year.
- Gains from Investment Securities improved to $2.2 million in Q1 2026 per TECX's latest filing, from $760000.0 in the prior quarter.
- Over five years, Gains from Investment Securities peaked at $7.6 million in Q2 2023 and troughed at -$887000.0 in Q4 2024.
- A 5-year average of $1.9 million and a median of $934500.0 in 2024 frame the typical range for Gains from Investment Securities.
- On a YoY basis, Gains from Investment Securities climbed as much as 481181.7% in 2024 and fell as far as 44250.0% in 2024.
- A 5-year view of Gains from Investment Securities shows it stood at -$9000.0 in 2022, then soared by 77.78% to -$2000.0 in 2023, then sank by 44250.0% to -$887000.0 in 2024, then jumped by 185.68% to $760000.0 in 2025, then surged by 186.38% to $2.2 million in 2026.
- Business Quant data shows TECX's Gains from Investment Securities at $2.2 million in Q1 2026, $760000.0 in Q4 2025, and $31891.0 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - |
| 10 | Tectonic Therapeutic | 528.16 Mn | 291.27 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.18 Mn |
| Mar 31, 2026 | 2.18 Mn |
| Dec 31, 2025 | 760,000.00 |
| Dec 31, 2025 | 760,000.00 |
| Mar 31, 2025 | 31,891.00 |
| Mar 31, 2025 | 31,891.00 |
| Dec 31, 2024 | -887,000.00 |
| Dec 31, 2024 | -887,000.00 |
| Sep 30, 2024 | 934,500.00 |
| Sep 30, 2024 | 934,500.00 |
| Jun 30, 2024 | 264,000.00 |
| Jun 30, 2024 | 264,000.00 |
| Mar 31, 2024 | 4.81 Mn |
| Mar 31, 2024 | 4.81 Mn |
| Dec 31, 2023 | -2,000.00 |
| Dec 31, 2023 | -2,000.00 |
| Sep 30, 2023 | 5.92 Mn |
| Sep 30, 2023 | 5.92 Mn |
| Jun 30, 2023 | 7.57 Mn |
| Jun 30, 2023 | 7.57 Mn |